Mesothelin, Calretinin, and Megakaryocyte Potentiating Factor as Biomarkers of Malignant Pleural Mesothelioma.
Carmina Jiménez-RamírezSwaantje CasjensCuauhtémoc Arturo Juárez-PérezIrina RaikoLuz M Del RazoDirk TaegerEmma S Calderón-ArandaHans-Peter RihsLeonor Concepción Acosta-SaavedraDaniel Gilbert WeberAlejandro Cabello-LópezBeate PeschMaría Dolores Ochoa-VázquezKatarzyna BurekLuis Torre-BouscouletJosé Rogelio Pérez-PadillaErik Marco García-BazanThomas BrüningGeorg JohnenGuadalupe Aguilar-MadridPublished in: Lung (2019)
To our knowledge, this is the first study evaluating a combination of mesothelin, calretinin, and MPF, and demonstrating a sex effect for calretinin. The biomarker panel showed a good performance in a Mestizo-Mexican population, with high sensitivity and specificity for the diagnosis of MPM.
Keyphrases